ADULT;
ARTICLE;
ATTITUDE;
BEHAVIOR;
COMMUNITY;
FEMALE;
HEALTH CARE PERSONNEL;
HEALTH EDUCATION;
HUMAN;
INFLUENZA;
MALE;
PANDEMIC;
PRESENTEEISM;
UNITED STATES;
VACCINATION;
WORKER;
ADULT;
AGED;
ATTITUDE OF HEALTH PERSONNEL;
CROSS INFECTION;
FEMALE;
HUMANS;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
KANSAS;
MALE;
MIDDLE AGED;
QUESTIONNAIRES;
VACCINATION;
The economic impact of pandemic influenza in the United States: priorities for intervention
Meltzer M.I., Cox N.J., and Fukuda K. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect Dis 5 (1999) 659-671
Frequently asked questions. How much time does it take to develop and produce an influenza vaccine? Available from: http://www.pandemicflu.gov/faq/vaccines/1077.html. Accessed June 18, 2007.
Frequently asked questions. How much time does it take to develop and produce an influenza vaccine? Available from: http://www.pandemicflu.gov/faq/vaccines/1077.html. Accessed June 18, 2007.
4
39049179045
Pandemic influenza: overview of vaccines and antiviral drugs
Cox M.M. Pandemic influenza: overview of vaccines and antiviral drugs. Yale J Biol Med 78 (2005) 321-328
World Health Organization Writing Group. Non-pharamaceutical interventions for pandemic influenza: national and community measures
Bell D.M. World Health Organization Writing Group. Non-pharamaceutical interventions for pandemic influenza: national and community measures. Emerg Infect Dis 12 (2006) 88-94
Centers for Disease Control and Prevention. Experiences with influenza-like illness and attitudes regarding influenza prevention-United States, 2003-04 influenza season
Centers for Disease Control and Prevention. Experiences with influenza-like illness and attitudes regarding influenza prevention-United States, 2003-04 influenza season. MMWR Morb Mortal Wkly Rep 53 (2004) 1156-1158